Durvalumab Plus Tarlatamab Improves Overall Survival in First-Line Extensive-Stage Small Cell Lung Cancer
Elizabeth Mittendorf: Grateful to Represent ASCO at the KSMO Annual Meeting in Seoul
VIRO 2026 – Global Voices in Renal Oncology
Down Syndrome and Leukemia: How an Extra Copy of Chromosome 21 Changes Cancer Risk
Arlocabtagene Autoleucel Meets Primary Endpoint in Phase 2 QUINTESSENTIAL Trial for Multiple Myeloma
Cureety Acquires Reimagine Care, Assembling a Transatlantic Platform for Cancer Care Between Visits
Shaalan Beg: When AI Enters the Clinic
Pyxis Oncology Appoints Thomas Civik as CEO and Chairman of the Board
AACR Immuno-Oncology 2027: Discovery and Innovation in Cancer Immunology—Revolutionizing Treatment Through Immunotherapy, organized by the American Association for Cancer Research (AACR), will take place on 28 February–3 March 2027 at […]
